Andrew Moran, MD, MPH,  is a program director, researcher and a primary care physician. Dr. Moran’s chief interests are in hypertension control and cardiovascular disease prevention, with a focus on earlier life prevention and prevention in low and middle income countries.

Dr. Moran is Chief of Cardiosvascular Health Science at Resolve to Save Lives where he supports expansion of systematic hypertension control programs in 38 low- and middle- income countries. In this role he provides clinical, technical, and logistics support to in-country partners implementing hypertension control programs.

At Columbia University, Dr. Moran leads predictive modeling and economic analyses of major clinical trials, including the landmark SPRINT trial of intensive blood pressure treatment, and the Los Angeles Barber-Pharmacist Blood Pressure Lowering trial, which tested a barber-pharmacist collaboration to treat hypertension in African American men visiting barbershops in Los Angeles, California. He is a lead investigator for the American Heart Association RESTORE Network, which is dedicated to addressing social determinants of health which raise risk for hypertension in five U.S. Black communities. He also leads research projects related to national cardiovascular disease prevention policies including early prevention in young adults and children and the optimal approach to screening and treatment of familial hypercholesterolemia (one of three Tier 1 genomic conditions).

Dr. Moran led the global burden of ischemic heart disease analysis for the Global Burden of Disease 2010 Study and the cardiovascular disease clinical care quality section of the Disease Control Priorities in Developing Countries, third edition (DCP3) project. He served on the 2021 hypertension Guideline Development Group at the World Health Organization and serves on the Steering Committee of the World Hypertension League.